Blogs

Lovelace partners with Community Health Corporation to develop acute care hospital in Los Lunas

FOR IMMEDIATE RELEASE

A Statement from Community Health Corporation and Lovelace Health System

ALBUQUERQUE, NM – April 25, 2024 – Community Hospital Corporation (CHC) and Lovelace Health System (Lovelace) are pleased to partner with the County of Valencia, New Mexico (Valencia County), to expand access to healthcare services through the development of a new state-of-the-art acute care hospital in Los Lunas, New Mexico.

Lovelace Medical Center, Heart Hospital of New Mexico Name Joseph Brown as Chief Operating Officer

FOR IMMEDIATE RELEASE

ALBUQUERQUE, NM – April 22, 2024 – Lovelace Health System has named Joseph C. Brown, MHA, chief operating officer (COO) of Lovelace Medical Center and Heart Hospital of New Mexico at Lovelace Medical Center, effective May 6.

Making Sense of Women’s Health Tests and Screenings

Regular health checkups and screenings are important for all women, regardless of their health status. Tests and screenings serve as a preventive measure to safeguard long-term health. We understand that trying to determine which screenings to get and at what age one needs them can become overwhelming. Use this quick screening guide to care for your own health and encourage the women in your life to stay up-to-date on their health tests.

Recommended screenings and tests for women

Five questions about car seat safety in New Mexico

Parents and caregivers of infants, toddlers and older children need to know what kind of car seat must be in their cars to transport their youngsters safely.

Heart Hospital of New Mexico at Lovelace Medical Center performs the state’s first Pulsed Field Ablation for the treatment of atrial fibrillation

FOR IMMEDIATE RELEASE

ALBUQUERQUE – April 15, 2024 – Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) today announced the completion of New Mexico’s first FARAPULSE ™ Pulsed Field Ablation, a new alternative to standard-of-care thermal ablation, for the treatment of atrial fibrillation (AFib). A non-thermal approach for the treatment of intermittent AFib, it is proven to be an effective treatment option for patients while minimizing risks associated with thermal ablation.

Lovelace Medical Center performs first right robotic pleural biopsy

FOR IMMEDIATE RELEASE

ALBUQUERQUE – April 5, 2024 –Lovelace Medical Center (LMC) completed its first right robotic pleural biopsy. The minimally invasive thoracic procedure was performed by Luis Cerda, M.D., cardiothoracic surgeon with the New Mexico Heart Institute/Lovelace Medical Group, using Intuitive’s Da Vinci Xi robotic system, which makes smaller incisions than the traditional open procedure, resulting in less postoperative pain, reduced infection risk and quicker recovery and hospital stay.

Hip replacement surgeries return hiker’s joy of the outdoors

The driving force behind Jeanne Kuriyan is her active lifestyle and adventurous spirit.

“I have always been extremely active, with daily trips to the gym, coupled with a love of the outdoors,” said Kuriyan, 72, who lives in Corrales, NM with her husband, Jacob.

5 Ways to Decrease Your Risk of Colorectal Cancer

Colorectal cancer is the third most common cancer in both men and women; it is also the second leading cause of cancer-related deaths in the United States. March is Colorectal Cancer Awareness Month, a month set aside to increase awareness and education of colon cancer. According to the American Institute for Cancer Research, almost half (47%) of colorectal cancer could be prevented or significantly delayed with lifestyle and diet modifications. Here are five ways to help you fight colorectal cancer.

SCAD heart attack survivor praises staff at Heart Hospital

Heart disease is the leading cause of death for women, a condition very familiar to Taos, NM resident Kendra Bealor, 57.

Both sides of Bealor’s family have a history of the disease, so the symptoms of a heart attack are very familiar to her. But she was still surprised when the symptoms struck her one Christmas morning.

New Mexico Heart Institute/Lovelace Medical Group enrolls the world’s first patient in the RECOVER IV randomized trial comparing strategies for management of cardiogenic shock

FOR IMMEDIATE RELEASE

ALBUQUERQUE – January 8, 2024 – New Mexico Heart Institute/Lovelace Medical Group (NMHI) has enrolled the first patient in the world in the RECOVER IV randomized study comparing management strategies for patients with cardiogenic shock using the Impella CP®, an FDA-approved temporary heart pump, versus standard of care.